Reapplix
FranceEntry
2023
Hold
3yr
Status
Active
Who owns Reapplix?
Reapplix is a French MedTech company, currently owned by Lauxera Capital Partners since 2023 and Novo Holdings.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Lauxera Capital PartnersLauxera Growth I · 2022 · Growth
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2012 · present
Novo HoldingsActive
2012 · present(14yr) · Novo Holdings Seed Investments · 1999 · VC
Lauxera Capital PartnersActive
2023 · present(3yr) · Lauxera Growth I · 2022 · Growth
More from Lauxera Growth I
Other portfolio companies in the same fund.
Sweden
GermanyMore PE-backed in MedTech
Comparable medtech deals from other GPs.
USQuestions
Who owns Reapplix?
Reapplix is currently owned by Lauxera Capital Partners and Novo Holdings, through Lauxera Growth I, since 2023.
When did Lauxera Capital Partners and 1 other acquire Reapplix?
Lauxera Capital Partners and 1 other acquired Reapplix in 2023.
Who has owned Reapplix over time?
Reapplix has been through 2 private-equity ownership periods: Novo Holdings · via Novo Holdings Seed Investments · since 2012; Lauxera Capital Partners · via Lauxera Growth I · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue